There are 1105 resources available
664P - Chemotherapy combination regimens for EGFR-TKI resistant metastatic EGFR-mutated NSCLC: A systematic review and network meta-analysis
Presenter: Baodong Qin
Session: Poster Display session
Resources:
Abstract
665P - Real-world effectiveness and safety of first-line (1L) osimertinib for EGFR-mutated (EGFRm) advanced NSCLC: A prospective, multi-center, real-world study in China (FLOURISH Study)
Presenter: Jing Zheng
Session: Poster Display session
Resources:
Abstract
666P - First-line camrelizumab plus chemotherapy for brain metastases in NSCLC: The CTONG 2003 randomized controlled trial
Presenter: Jin-Ji Yang
Session: Poster Display session
Resources:
Abstract
667P - Furmonertinib 160mg as first-line treatment for metastatic EGFR mutation-positive non-small cell lung cancer (NSCLC) patients with central nervous system (CNS) metastases
Presenter: Yongchang Zhang
Session: Poster Display session
Resources:
Abstract
668P - The Impact of MTAP loss on response to immune checkpoint inhibitors in stage IV NSCLC: A prospective real-world analysis
Presenter: Aya El-Helali
Session: Poster Display session
Resources:
Abstract
669P - A retrospective observational study on the efficacy of local ablative therapy for oligoprogression in non-small cell lung cancer patients who responded to immunotherapy combined chemotherapy
Presenter: Shoichi Kuyama
Session: Poster Display session
Resources:
Abstract
670P - Phase III study of zipalertinib plus first-line (1L) platinum-based chemotherapy in patients (pts) with non-small cell lung cancer (NSCLC) harboring EGFR exon 20 insertion (ex20ins) mutations (REZILIENT3): Safety lead-in results
Presenter: Takayasu Kurata
Session: Poster Display session
Resources:
Abstract
671P - Radiomics models using machine learning algorithms to differentiate the primary focus of brain metastasis
Presenter: Yuping Xie
Session: Poster Display session
Resources:
Abstract
672P - Association between the administration time and therapeutic effect of nivolumab in patients with non-small cell lung cancer: A multicenter retrospective observational study
Presenter: Yuki Iwahashi
Session: Poster Display session
Resources:
Abstract
673P - Diagnosis and treatment of ROS1 fusion-positive non-small-cell lung cancer in China: Preliminary report of a nationwide survey
Presenter: Fei Zhou
Session: Poster Display session
Resources:
Abstract